| 1 |
34717971 | Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic. | 2022 Jan 30 |
1 |
| 2 |
35231586 | Addition of arginine hydrochloride and proline to the culture medium enhances recombinant protein expression in Brevibacillus choshinensis: The case of RBD of SARS-CoV-2 spike protein and its antibody. | 2022 Jun |
1 |
| 3 |
35575289 | In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain. | 2022 May 16 |
1 |
| 4 |
32995773 | Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates. | 2021 Apr 5 |
1 |
| 5 |
33653892 | Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model. | 2021 Mar 2 |
1 |
| 6 |
33975938 | An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines. | 2021 May 11 |
1 |
| 7 |
34461095 | SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity. | 2021 Oct |
1 |
| 8 |
34611365 | Expression and characterization of SARS-CoV-2 spike proteins. | 2021 Nov |
1 |
| 9 |
34987509 | An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection. | 2021 |
1 |
| 10 |
33236008 | An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines. | 2020 Nov 18 |
1 |